Медицинская литература. Новинки

 

 

 

 

 

 

ДИСФУНКЦИЯ ЩИТОВИДНОЙ ЖЕЛЕЗЫ И СИСТЕМА КРОВЕТВОРЕНИЯ

Вы можете загрузить полный текст статьи в формате pdf

Ключевые слова:

Литература:
1. Braverman L.E., Utiger R.D. The thyroid: a Fundamental and clinical text. 9th ed. Philadelphia: Lippicott Williams & Wilkins 2005.
595–598, 803–806.
2. Calhan T., Senateє E., Cebeci E. et al. A comparison of antineutrophil cytoplasmic antibody prevalence in patients treated and
untreated for hyperthyroidism. Endocrine 2010; 38 (2): 199–205.
3. Chadarevian R., Bruckert E., Leenhardt L. et al. Components of the
fibrinolytic system are differently altered in moderate and severe
hypothyroidism. J. Clin. Endocrinol. Metab. 2001; 86 (2):
732–737.
4. Chute J.P., Tyan C.P., Sladek G. et al. Exacerbation of warfarininduced anticoagulation by hyperthyroidism.Endocr Pract.
1997; 3: 77.
5. Das K.C., Mukherjee M., Sarkar T.K. et al. Erythropoiesis and erythropoietin in hypo and hyperthyroidism. J. Clin. Endocrinol.
Metab. 1975; 40 (2): 211–220.
6. Erem C. Coagulation and fibrinolysis in thyroid dysfunction.
Endocrine 2009; 36 (1): 110–118.
7. Federici A.B. Acquired von Willebrand syndrome associated with
hypothyroidism: a mild bleeding disorder to be further investigated. Semin. Thromb. Hemost. 2011; 37 (1): 35–40.
8. Fein H.G., Rivlin R.S. Anemia in thyroid diseases. Med. Clin.
N. Am. 1975; 59 (5): 1133–1145.
9. Ford H.C., Carter J.M. The haematology of hyperthyroidism:
abnormalities of erythrocytes, leucocytes, thrombocytes and
haemostasis. Postgrad. Med. J. 1988; 64 (756): 735–742.
10. Golde D.W., Bersch N., Chopra I.J., Cline M.J. Thyroid hormones
stimulate erythropoiesis in vitro. Br. J. Haematol. 1977; 37 (2):
173–177.
11. Horton L., Coburn R.J., England J.M., Himsworth R.L. The haematology of hypothyroidism. Quart. J. Med. 1976; 45 (177): 101–123.
12. Kellett H.A., Sawers J.S.A., Boulton F.E. et al. Problems of anticoagulation with warfarin in hyperthyroidism. Quart. J. Med. 1986;
58: 43.
13. Marongiu F., Conti M., Murtas M.L. et al. Anticardiolipin antibodies in Graves’ disease: relationship with thrombin activity in vivo.
Thromb. Res. 1991; 64: 745.
14. Michiels J.J., Budde U., van der Planken M. et al. Acquired von
Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management. Best. Pract. Res. Clin.
Haematol. 2001; 14 (2): 401–436.
15. Michiels J.J., Schroyens W., Berneman Z., van der Planken M.
Acquired von Willebrand syndrome type 1 in hypothyroidism:
reversal after treatment with thyroxine. Clin. Appl. Thromb.
Hemost. 2001; 7 (2): 113–115.
16. Ohashi H., Itoh M. Effects of thyroid hormones on the lymphocyte
phenotypes in rats: changes in lymphocyte subsets related to thyroid function. Endocr. Regul. 1994; 28 (3): 117–123.
17. Olukman O., Sahin U., Kavakli T., Kavakli K. Investigation of
acquired von Willebrand Syndrome in children with hypothyroidism: reversal after treatment with thyroxine. J. Pediatr.
Endocrinol. Metab. 2010; 23 (9): 967–974.
18. Omar S., Hadj Taeib S., Kanoun F. et al. Erythrocyte abnormalities
in thyroid dysfunction. Tunis Med. 2010; 88 (11): 783–788.
19. Sievert R., Goldstein M.L., Surks M.I. Graves’ disease and autoimmune factor VIII deficiency. Thyroid 1996; 6: 245.
20. Yango J., Alexopoulou O., Eeckhoudt S. et al. Evaluation of the
respective influence of thyroid hormones and TSH on blood coagulation parameters after total thyroidectomy. Eur. J. Endocrinol. 2011; 164 (4): 599–603.
21. Yoshida K. Erythrocyte carbonic anhydrase I and zinc concentrations in thyrotoxicosis reflect integrated thyroid hormone levels over
the previous few months. Rinsho Byori. 2007; 55 (6): 560–565.
22. Zeigler Z.R., Hasiba U., Lewis J.H. et al. Hemostatic defects in
response to aspirin challenge in hypothyroidism. Am. J.
Hematol. 1986; 23: 391.

Thyroid dysfunction and hematopoietic system

Keywords: